Terminal differentiation exerts a remarkably tight control on cell proliferation. However, the oncogenic products of DNA tumor viruses, such as adenovirus E1A, can force postmitotic cells to proliferate, thus representing a powerful tool to study progression into S phase. In this study, we identified the gene encoding Np95, a murine nuclear phosphoprotein, as an early target of E1A-induced transcriptional events. In terminally differentiated (TD) cells, the activation of Np95 was specifically induced by E1A, but not by overexpression of E2F-1 or of the cyclin E (cycE)–cyclin-dependent kinase 2 (cdk2) complex. In addition, the concomitant expression of Np95 and of cycE–cdk2 was alone sufficient to induce S phase in TD cells. In NIH-3T3 cells, the expression of Np95 was tightly regulated during the cell cycle, and its functional ablation resulted in abrogation of DNA synthesis. Thus, expression of Np95 is essential for S phase entry. Previous evidence suggested that E1A, in addition to its well characterized effects on the pRb/E2F-1 pathway, activates a parallel and complementary pathway that is also required for the reentry in S phase of TD cells (Tiainen, M., D. Spitkousky, P. Jansen-Dürr, A. Sacchi, and M. Crescenzi. 1996. Mol. Cell. Biol. 16:5302–5312). From our results, Np95 appears to possess all the characteristics to represent the first molecular determinant identified in this pathway.
Skip Nav Destination
Article navigation
10 June 2002
Report|
June 10 2002
Np95 is regulated by E1A during mitotic reactivation of terminally differentiated cells and is essential for S phase entry
Ian Marc Bonapace,
Ian Marc Bonapace
1The FIRC Institute for Molecular Oncology, 20134 Milan, Italy
2Dipartimento di Biologia Strutturale e Funzionale, Universita' dell'Insubria, Busto Arsizio, 21052, Italy
Search for other works by this author on:
Lucia Latella,
Lucia Latella
3Laboratory of Comparative Toxicology and Ecotoxicology, Istituto Superiore di Sanità, 00161 Rome, Italy
Search for other works by this author on:
Roberto Papait,
Roberto Papait
1The FIRC Institute for Molecular Oncology, 20134 Milan, Italy
2Dipartimento di Biologia Strutturale e Funzionale, Universita' dell'Insubria, Busto Arsizio, 21052, Italy
Search for other works by this author on:
Francesco Nicassio,
Francesco Nicassio
1The FIRC Institute for Molecular Oncology, 20134 Milan, Italy
4European Institute of Oncology, 20141, Milan, Italy
Search for other works by this author on:
Alessandra Sacco,
Alessandra Sacco
3Laboratory of Comparative Toxicology and Ecotoxicology, Istituto Superiore di Sanità, 00161 Rome, Italy
Search for other works by this author on:
Masahiro Muto,
Masahiro Muto
5Division of Biology and Oncology, National Institute of Radiological Sciences, Inage-ku, Chiba 263-8555, Japan
Search for other works by this author on:
Marco Crescenzi,
Marco Crescenzi
3Laboratory of Comparative Toxicology and Ecotoxicology, Istituto Superiore di Sanità, 00161 Rome, Italy
Search for other works by this author on:
Pier Paolo Di Fiore
Pier Paolo Di Fiore
1The FIRC Institute for Molecular Oncology, 20134 Milan, Italy
4European Institute of Oncology, 20141, Milan, Italy
6Dipartimento di Medicina Chirurgia ed Odontoiatria, Universita' degli Studi di Milano, 20122 Milan, Italy
Search for other works by this author on:
Ian Marc Bonapace
1The FIRC Institute for Molecular Oncology, 20134 Milan, Italy
2Dipartimento di Biologia Strutturale e Funzionale, Universita' dell'Insubria, Busto Arsizio, 21052, Italy
Lucia Latella
3Laboratory of Comparative Toxicology and Ecotoxicology, Istituto Superiore di Sanità, 00161 Rome, Italy
Roberto Papait
1The FIRC Institute for Molecular Oncology, 20134 Milan, Italy
2Dipartimento di Biologia Strutturale e Funzionale, Universita' dell'Insubria, Busto Arsizio, 21052, Italy
Francesco Nicassio
1The FIRC Institute for Molecular Oncology, 20134 Milan, Italy
4European Institute of Oncology, 20141, Milan, Italy
Alessandra Sacco
3Laboratory of Comparative Toxicology and Ecotoxicology, Istituto Superiore di Sanità, 00161 Rome, Italy
Masahiro Muto
5Division of Biology and Oncology, National Institute of Radiological Sciences, Inage-ku, Chiba 263-8555, Japan
Marco Crescenzi
3Laboratory of Comparative Toxicology and Ecotoxicology, Istituto Superiore di Sanità, 00161 Rome, Italy
Pier Paolo Di Fiore
1The FIRC Institute for Molecular Oncology, 20134 Milan, Italy
4European Institute of Oncology, 20141, Milan, Italy
6Dipartimento di Medicina Chirurgia ed Odontoiatria, Universita' degli Studi di Milano, 20122 Milan, Italy
Address correspondence to Pier Paolo Di Fiore, The FIRC Institute for Molecular Oncology, Via Serio 21, 20134 Milan, Italy. Tel.: 39-02-57489855. Fax: 39-02-57489851. E-mail: [email protected]
*
Abbreviations used in this paper: cdk2, cyclin-dependent kinase 2; cycE, cyclin E; MOI, multiplicity of infection; pfu, plaque-forming unit; pRb, retinoblastoma protein; TD, terminally differentiated.
Received:
January 04 2002
Revision Received:
April 24 2002
Accepted:
May 06 2002
Online ISSN: 1540-8140
Print ISSN: 0021-9525
The Rockefeller University Press
2002
J Cell Biol (2002) 157 (6): 909–914.
Article history
Received:
January 04 2002
Revision Received:
April 24 2002
Accepted:
May 06 2002
Citation
Ian Marc Bonapace, Lucia Latella, Roberto Papait, Francesco Nicassio, Alessandra Sacco, Masahiro Muto, Marco Crescenzi, Pier Paolo Di Fiore; Np95 is regulated by E1A during mitotic reactivation of terminally differentiated cells and is essential for S phase entry . J Cell Biol 10 June 2002; 157 (6): 909–914. doi: https://doi.org/10.1083/jcb.200201025
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionEmail alerts
Advertisement
Advertisement